Uncategorized

Serum Biomarkers Market – Global Outlook and Forecast 2022-2028

Serum biomarkers are proteins generally detected in urine, blood, and Others bodily fluids produced by malignant cells or in reaction to presence/absence of malignant cells. Preferably, biomarkers should have at least one or more than one of the following properties: prompt detection of cancer within high risk population, diagnosis of specific type of cancer, prediction in its growth, screen its treatment response, and detect early recurrence.

This report contains market size and forecasts of Serum Biomarkers in global, including the following market information:

Global Serum Biomarkers Market Revenue, 2017-2022, 2023-2028, ($ millions)

 

Global Serum Biomarkers Market Sales, 2017-2022, 2023-2028, (K MT)

 

Global top five Serum Biomarkers companies in 2021 (%)

The global Serum Biomarkers market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hepatocellular Carcinoma Serum Biomarkers Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Serum Biomarkers include Roche, Pfizer, Novartis, Abbott, BD, Merck, Eli Lilly, Agilent Technologies and Boehringer Ingelheim, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Serum Biomarkers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Serum Biomarkers Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Serum Biomarkers Market Segment Percentages, by Type, 2021 (%)

Hepatocellular Carcinoma Serum Biomarkers

Lung Cancer Serum Biomarkers

Pancreatic & Biliary Tract Cancer Serum Biomarkers

Breast Cancer Serum Biomarkers

Glioblastoma Serum Biomarkers

Others

Global Serum Biomarkers Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Serum Biomarkers Market Segment Percentages, by Application, 2021 (%)

Hospitals

Academic & Research Institutes

Ambulatory Surgical Centers

Others

Global Serum Biomarkers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Serum Biomarkers Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Serum Biomarkers revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Serum Biomarkers revenues share in global market, 2021 (%)

Key companies Serum Biomarkers sales in global market, 2017-2022 (Estimated), (K MT)

Key companies Serum Biomarkers sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Roche

Pfizer

Novartis

Abbott

BD

Merck

Eli Lilly

Agilent Technologies

Boehringer Ingelheim

AstraZeneca

Bristol-Myers Squibb

Novo Nordisk

Allergan

Gilead

Table of content

1 Introduction to Research & Analysis Reports
1.1 Serum Biomarkers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Serum Biomarkers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Serum Biomarkers Overall Market Size
2.1 Global Serum Biomarkers Market Size: 2021 VS 2028
2.2 Global Serum Biomarkers Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Serum Biomarkers Sales: 2017-2028
3 Company Landscape
3.1 Top Serum Biomarkers Players in Global Market
3.2 Top Global Serum Biomarkers Companies Ranked by Revenue
3.3 Global Serum Biomarkers Revenue by Companies
3.4 Global Serum Biomarkers Sales by Companies
3.5 Global Serum Biomarkers Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Serum Biomarkers Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Serum Biomarkers Product Type
3.8 Tier 1, Tier 2 and Tier 3 Serum Biomarkers Players in Global Market
3.8.1 List of Global Tier 1 Serum Biomarkers Companies
3.8.2 List of Global Tier 2 and Tier 3 Serum Biomarkers Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Serum Biomarkers Market Size Markets, 2021 & 2028
4.

 

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
Visit: https://www.primemarketreports.com/

Similar Reports:

Serum Cancer Biomarkers Market – Global Outlook and Forecast 2022-2028

Global Serum Biomarkers Market Insights and Forecast to 2028

Global Serum Cancer Biomarkers Market Insights and Forecast to 2028

Global Serum Biomarkers Market Research Report 2021
 

Related Articles

Back to top button